https://doi.org/10.1038/onc.2009.335
A
Amanda Leiter
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
87
Papers
2.2K
Citations
16
h-index
22
i10-index
Amanda Leiter is an academic researcher from New York Proton Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Legal Systems and Judicial Processes. The author has an h-index of 16, co-authored 74 publications.
ORCID: 0000-0001-9072-5512Papers by this author
worksCapsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway
2009 · Oncogene · 198 citations
Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade
2020 · Cancer Treatment and Research Communications · 14 citations
https://doi.org/10.1016/j.ctarc.2020.100216
Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis
2022 · Discover Oncology · 11 citations
https://doi.org/10.1007/s12672-022-00538-6
Cushing Disease Treated Successfully With Metyrapone During Pregnancy
2021 · AACE Clinical Case Reports · 9 citations
https://doi.org/10.1016/j.aace.2021.10.004
"The Perils of a Half-Built Bridge: Risk Perception, Shifting Majorities, and the Nuclear Power Debate"
2008 · eYLS (Yale Law School) · 1 citations
https://doi.org/10.15779/z384g14
Utility Air Regulatory Group v. EPA: A Shot Across the Bow of the Administrative State
2014 · eYLS (Yale Law School) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat